📖 Approx. 8 minutes ／ Updated 2026.05.08
Clinics located in rural and suburban areas are vital hubs supporting the health of local residents. However, in recent years, many clinics have faced the serious challenge of a shortage of successors, leading to an increasing number of cases where they are on the verge of closure. This situation can have a significant impact not only on the maintenance of the healthcare delivery system but also on the very fabric of the local community. In this context, third-party succession through M&A (Mergers and Acquisitions) is drawing attention as an effective option for ensuring the continuity of regional healthcare. This article, from the perspective of healthcare industry specialists, explains the unique issues surrounding business succession for rural and suburban clinics and solutions utilizing M&A.
Successor Issues for Rural and Suburban Clinics and Their Impact on Regional Healthcare
The regional disparity of physicians has been a long-standing issue in Japan’s medical field, with physician recruitment remaining difficult, particularly in rural and suburban areas. Even when expecting succession within the family, children often choose to work in urban areas, making it difficult for intra-family succession to be established in reality. This shortage of successors, combined with the aging of practitioners, is forcing many clinics to close.
The closure of a clinic is not merely the disappearance of a medical institution. For local patients, losing their primary care physician can worsen access to healthcare, making it difficult to receive timely medical attention. Especially in increasingly aging rural areas, the reduction in medical facilities can create healthcare deserts, directly impacting residents’ healthspan and quality of life. Furthermore, closures also affect the local economy and lead to job losses for healthcare professionals. To avoid such situations and preserve regional healthcare, third-party succession through M&A plays a crucial role. It is expected that matching with diverse potential buyers, such as physicians interested in regional healthcare, medical corporations considering branch expansion, or physicians wishing to return to their hometowns (U-turn/I-turn), will help maintain and strengthen the healthcare delivery system.
Legal and Practical Issues in Medical Corporation Systems and Business Succession
M&A of medical institutions requires an understanding of special systems stipulated by the Medical Care Act, which differs from typical corporate M&A. In particular, the type of medical corporation significantly influences the succession scheme.
- Medical Corporations with Equity Stakes: This was the mainstream form in the past, where property rights in the corporation are recognized according to equity stakes. These equity stakes are subject to inheritance and transfer, potentially incurring gift or inheritance taxes based on their valuation. When succeeding, the valuation of equity stakes and the method of their transfer or gifting are important issues.
- Medical Corporations without Equity Stakes: All new establishments are now of this type, and there is no concept of equity stakes. Instead, a “fund system” can be established, granting fund contributors the right to claim repayment of the fund upon the dissolution of the corporation. Changes in shareholders (directors) are made according to procedures stipulated in the articles of incorporation, but since they do not involve property rights, the tax treatment at the time of succession differs from that of corporations with equity stakes.
Furthermore, in the business succession of medical corporations, the change of shareholders (directors) is essential. Since shareholders form the decision-making body of the corporation, it is necessary to change shareholders through appropriate procedures to establish a post-succession management structure. Additionally, with the change of clinic proprietors, it is often necessary to re-obtain or transfer permits from public health centers and prefectural governments. This involves a wide range of administrative procedures, including permits for clinic establishment, medical equipment installation, and approvals for various facility standards. Properly navigating these procedures requires in-depth knowledge and experience of the Medical Care Act and related laws.
Valuation of Business Value and Estimated Transfer Prices for Rural Clinics
The valuation of a clinic’s business value is an extremely important process for both sellers and buyers. For rural clinics, different valuation factors may be considered compared to urban clinics. Generally, the following factors are emphasized in valuation:
- Profitability: Medical revenue, profit margins, and cost structure over the past few years.
- Asset Value: Land and buildings (if self-owned), medical equipment, brand recognition within the service area, etc.
- Future Potential: Demographic trends in the surrounding area, competitive landscape, and the possibility of responding to future medical fee revisions and facility standards.
While the absolute transfer price for rural clinics tends to be lower than in urban areas, their regional exclusivity and long-standing stable patient base can be valued as strengths. Additionally, clinics with specialized fields or high levels of expertise may receive higher valuations due to their rarity. Medical fee revisions directly impact a clinic’s future revenue, so their trends are carefully considered during valuation. Whether specific facility standards are met also affects the medical services that can be provided and profitability, making it a valuation item.
The specific estimated transfer price varies greatly depending on the medical specialty, annual sales, profit margin, location, and equipment status. The following table provides a general guideline for the transfer price range for major medical specialties. Please note that this is a general trend and may vary significantly in individual cases.
| Medical Specialty | Estimated Transfer Price Range (JPY 100 million) |
|---|---|
| Internal Medicine | 1.0 – 1.5 billion yen |
| Orthopedics | 1.5 – 2.0 billion yen |
| Dermatology | 0.8 – 1.2 billion yen |
| Ophthalmology | 1.2 – 1.8 billion yen |
| Dentistry | 0.5 – 1.0 billion yen |
| Cosmetic Surgery/Dermatology | 3.0 billion yen or more (due to high profitability/brand power) |
Generally, for rural clinics with annual sales of around 80 million to 150 million yen, the transfer price may be in the range of 20 million to 70 million yen. However, this is only an estimate, and a detailed appraisal based on individual circumstances is essential.
Taxation and Succession Process in Medical M&A
The tax treatment in medical M&A varies significantly depending on the succession scheme and the corporate form of the medical institution involved. In particular, capital gains tax incurred by the seller directly affects the net proceeds, requiring thorough consideration in advance. The tax rates and calculation methods differ between transferring a clinic as a sole proprietorship and transferring a medical corporation (with or without equity stakes).
- For Sole Proprietors: Capital gains tax is levied on the profit from the transfer of business assets (medical equipment, interior furnishings, etc.). If real estate is transferred simultaneously, the capital gains tax on real estate must also be considered.
- For Medical Corporations with Equity Stakes: Capital gains tax (separate taxation) is levied on the profit from the transfer of equity stakes, similar to individual shareholders.
- For Medical Corporations without Equity Stakes: When the business itself is transferred, taxes are levied on the corporation. In principle, there is no tax liability for individual shareholders (directors), but caution is needed regarding the tax treatment associated with fund repayment.
Furthermore, medical corporations are generally exempt from business tax, but if they engage in certain profit-making businesses (e.g., health check-up services, sales of health foods), business tax may be levied on those portions. These tax issues are directly linked to the success of M&A, making expert advice indispensable.
The standard process for medical M&A generally proceeds in the following steps:
- Free Consultation & Initial Assessment (30-60 minutes): Share the possibilities and challenges of M&A with specialists.
- Execution of Non-Disclosure Agreement (NDA) & Preliminary Assessment (1-2 weeks): Protect confidential information and obtain an approximate business valuation.
- Matching (1-3 months): Search for potential buyers that meet the transfer conditions.
- Meetings & Execution of Letter of Intent (LOI) (1-2 months): Direct meetings between seller and buyer, forming basic agreement.
- Due Diligence (DD) & Execution of Share Purchase Agreement (SPA) (2-3 months): Buyer’s detailed investigation (financial, legal, labor, compliance with medical regulations, etc.) and final adjustment of contract terms.
- Closing & Post-Merger Integration (PMI): Execution of M&A and support for smooth post-succession integration.
This entire process typically takes about 6 months to 1 year, but the duration may vary depending on the case. Due diligence, in particular, is a crucial stage for identifying hidden risks of the target clinic, and investigations from a specialized perspective on medical laws and permits are essential.
Succession Strategy for Rural Clinics Aligned with Regional Healthcare Plans
When considering business succession for rural and suburban clinics, alignment with the Regional Healthcare Plan formulated by each prefecture is an extremely important factor. The Regional Healthcare Plan estimates future medical demand and the required number of hospital beds and functions to optimize the healthcare delivery system, influencing new clinic establishments, functional changes, and succession.
For successful succession in rural areas, collaboration with local governments and medical associations is indispensable. Many local governments have physician attraction programs and subsidy systems to maintain and secure regional healthcare. Utilizing these systems can lead to securing potential buyers and stabilizing post-succession management. Furthermore, physicians wishing to relocate to their hometowns (U-turn/I-turn) have a high desire to contribute to the region and are expected to be new pillars of rural clinics. Actively seeking to match with such physicians is also an effective strategy.
In rural areas with rapidly advancing aging populations, the demand for home healthcare and visiting nursing services continues to expand. By strengthening and expanding home healthcare services in addition to outpatient care after M&A, clinics can better meet regional medical needs and enhance their business growth potential. When considering succession, conducting medium- to long-term service area population forecasts that consider surrounding population trends, especially the influx and outflow of young people and the aging rate, allows for a more concrete depiction of future business strategies.
Professional Perspective for Successful M&A of Rural and Suburban Clinics
Business succession for rural and suburban clinics is a crucial initiative that simultaneously addresses the pressing issue of successor shortages and the social mission of continuing regional healthcare. However, it requires a wide range of specialized knowledge, including the complexity of medical corporation systems, tax-related peculiarities, the cumbersome nature of permit procedures, and adaptation to regional healthcare plans.
At M&A Medical, we deeply understand these industry-specific issues and propose optimal succession schemes by accurately grasping the needs of both sellers and buyers. We provide support to facilitate smooth business succession by maximizing the potential value of individual clinics, looking towards the future of regional healthcare. To proceed with the complex M&A process with peace of mind, please consult with M&A specialists in the healthcare industry.
For consultations regarding the succession of rural and suburban clinics, please feel free to contact M&A Medical. Our specialized consultants will provide free, tailored solutions based on your clinic’s situation.
Consultations on Medical Succession with M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the success of transfers for clinics and medical corporations struggling with successor shortages, as well as strategic acquisitions, on a success-fee basis.
- Initial consultation and preliminary assessment are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeds after signing NDA)
- Service available nationwide in all 47 prefectures and for all medical specialties
Please consult with us early, even if you are just looking to understand market trends, have no successor, or are considering joining a group.